Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayla T O'Toole

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|February 27, 2026
Unraveling the Enigma of Melanoma Brain Metastasis: New Molecular Insights and Therapeutic DirectionsKayla T O'Toole, Brandon M Roan, Timothy M Hardman, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Characterization of the BRAF interactome identifies BRAF <sup>V600E</sup> <=>TP53 interaction in melanomaKayla T O'Toole, Adamaris Martinez, Brandon Murphy, et al.
Elife|August 30, 2024
Inhibition of ULK1/2 and KRAS<sup>G12C</sup> controls tumor growth in preclinical models of lung cancerPhaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Inhibition of ULK1/2 and KRAS <sup>G12C</sup> controls tumor growth in preclinical models of lung cancerPhaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, et al.
Cell Reports|March 21, 2026
Identification and characterization of BRAF⇔TP53 interactions in melanomaKayla T O'Toole, Adamaris Martinez, Brandon Murphy, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated MelanomaMona Foth, Wontak Kim, Kayla T O'Toole, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|February 27, 2026
Unraveling the Enigma of Melanoma Brain Metastasis: New Molecular Insights and Therapeutic DirectionsKayla T O'Toole, Brandon M Roan, Timothy M Hardman, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Characterization of the BRAF interactome identifies BRAF <sup>V600E</sup> <=>TP53 interaction in melanomaKayla T O'Toole, Adamaris Martinez, Brandon Murphy, et al.
Elife|August 30, 2024
Inhibition of ULK1/2 and KRAS<sup>G12C</sup> controls tumor growth in preclinical models of lung cancerPhaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Inhibition of ULK1/2 and KRAS <sup>G12C</sup> controls tumor growth in preclinical models of lung cancerPhaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, et al.
Cell Reports|March 21, 2026
Identification and characterization of BRAF⇔TP53 interactions in melanomaKayla T O'Toole, Adamaris Martinez, Brandon Murphy, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated MelanomaMona Foth, Wontak Kim, Kayla T O'Toole, et al.
Pageof 1